Irritable Bowel Syndrome, An Issue of Gastroenterology Clinics, 1st Edition
Author :
William D. Chey
This comprehensive update on irritable bowel syndrome addresses both the state of art diagnosis and treatment as well as emerging therapies and future directions. Worldwide authority, Dr. Eammon Quigley, contributes an article on Therapies Aimed at t ...view more
This comprehensive update on irritable bowel syndrome addresses both the state of art diagnosis and treatment as well as emerging therapies and future directions. Worldwide authority, Dr. Eammon Quigley, contributes an article on Therapies Aimed at the Gut Microflora and Inflammation. Other highlights include articles devoted to genetics, biomarkers, and symptom-based diagnostic criteria.
This comprehensive update on irritable bowel syndrome addresses both the state of art diagnosis and treatment as well as emerging therapies and future directions. Worldwide authority, Dr. Eammon Quigley, contributes an article on Therapies Aimed at the Gut Microflora and Inflammation. Other highlights include articles devoted to genetics, biomarkers, and symptom-based diagnostic criteria.
Author Information
By William D. Chey, MD, AGAF, FACG, FACP, Co-Editor-in-Chief, Clinical & Translational Gastroenterology; Professor of Medicine; Director, GI Physiology Laboratory and Co-Director, Michigan Bowel Control Program, University of Michigan Health System, Ann Arbor, MI
https://www.us.elsevierhealth.com/irritable-bowel-syndrome-an-issue-of-gastroenterology-clinics-9781455704507.html6501Irritable Bowel Syndrome, An Issue of Gastroenterology Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781455704507_7.jpg74.2498.99USDInStock/Medicine/Gastroenterology/Clinics/Clinics1174388725525504113841826925145120<P>This comprehensive update on irritable bowel syndrome addresses both the state of art diagnosis and treatment as well as emerging therapies and future directions. Worldwide authority, Dr. Eammon Quigley, contributes an article on Therapies Aimed at the Gut Microflora and Inflammation. Other highlights include articles devoted to genetics, biomarkers, and symptom-based diagnostic criteria.</P> <P>This comprehensive update on irritable bowel syndrome addresses both the state of art diagnosis and treatment as well as emerging therapies and future directions. Worldwide authority, Dr. Eammon Quigley, contributes an article on Therapies Aimed at the Gut Microflora and Inflammation. Other highlights include articles devoted to genetics, biomarkers, and symptom-based diagnostic criteria.</P>00add-to-cart97814557045072011 and earlierProfessionalBy William D. Chey, MD, AGAF, FACG, FACP20111Book152w x 229h (6.00" x 9.00")Saunders280Mar 22, 2011IN STOCK - This may take up to 5 business days to shipBy <STRONG>William D. Chey</STRONG>, MD, AGAF, FACG, FACP, Co-Editor-in-Chief, Clinical & Translational Gastroenterology; Professor of Medicine; Director, GI Physiology Laboratory and Co-Director, Michigan Bowel Control Program, University of Michigan Health System, Ann Arbor, MIClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
